Skip to content

Insider · CIK 0001960048

Cowan Elvia

Reports to the SEC for 1 company · SAN CARLOS, CA

Transactions

50

Companies

1

Filings

7

CIK

0001960048

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-10-05PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2026-10-05PCVXVaxcyte, Inc.M Exercise/Conversion+$492K
2026-10-05PCVXVaxcyte, Inc.S Sale−$1.65M
2026-09-08PCVXVaxcyte, Inc.F Tax Payment−$80.1K
2026-09-02PCVXVaxcyte, Inc.F Tax Payment−$20.1K
2026-08-31PCVXVaxcyte, Inc.F Tax Payment−$14.8K
2026-04-07PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2026-04-07PCVXVaxcyte, Inc.S Sale−$180K
2026-04-07PCVXVaxcyte, Inc.M Exercise/Conversion+$77.8K
2026-03-17PCVXVaxcyte, Inc.S Sale−$22.8K
2026-03-17PCVXVaxcyte, Inc.S Sale−$82.4K
2026-03-11PCVXVaxcyte, Inc.M Exercise/Conversion+$64.8K
2026-03-11PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2026-03-11PCVXVaxcyte, Inc.S Sale−$146K
2026-03-09PCVXVaxcyte, Inc.F Tax Payment−$29.4K
2026-03-02PCVXVaxcyte, Inc.F Tax Payment−$20.2K
2026-02-28PCVXVaxcyte, Inc.F Tax Payment−$15.1K
2026-02-26PCVXVaxcyte, Inc.M Exercise/Conversion+$200K
2026-02-26PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award—
2026-02-26PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2026-02-26PCVXVaxcyte, Inc.A Award—
2025-12-23PCVXVaxcyte, Inc.G Gift—
2025-12-23PCVXVaxcyte, Inc.S Sale−$322K
2025-12-23PCVXVaxcyte, Inc.S Sale−$235K
2025-09-08PCVXVaxcyte, Inc.F Tax Payment−$15.6K
2025-09-07PCVXVaxcyte, Inc.A Award—
2025-09-02PCVXVaxcyte, Inc.F Tax Payment−$7,637.52
2025-09-02PCVXVaxcyte, Inc.F Tax Payment−$10.3K
2025-08-29PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award—
2025-03-03PCVXVaxcyte, Inc.F Tax Payment−$23.4K
2025-02-28PCVXVaxcyte, Inc.F Tax Payment−$17.7K
2025-02-27PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award—
2025-02-27PCVXVaxcyte, Inc.A Award—
2024-12-16PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2024-12-16PCVXVaxcyte, Inc.M Exercise/Conversion+$200K
2024-11-07PCVXVaxcyte, Inc. · Performance Stock Option (right to buy)A Award—
2024-09-03PCVXVaxcyte, Inc.S Sale−$538K
2024-09-03PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2024-09-03PCVXVaxcyte, Inc.F Tax Payment−$126K
2024-09-03PCVXVaxcyte, Inc.M Exercise/Conversion+$130K
2024-07-16PCVXVaxcyte, Inc.M Exercise/Conversion+$130K
2024-07-16PCVXVaxcyte, Inc.S Sale−$425K
2024-07-16PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2024-07-08PCVXVaxcyte, Inc.S Sale−$400K
2024-07-08PCVXVaxcyte, Inc.M Exercise/Conversion+$130K
2024-07-08PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2024-03-02PCVXVaxcyte, Inc.F Tax Payment−$23.2K
2024-03-01PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2024-03-01PCVXVaxcyte, Inc.S Sale−$367K
2024-03-01PCVXVaxcyte, Inc.S Sale−$170K

Recent filings

7

Companies

1

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300

SAN CARLOS, CA, 94070